Skip to main content
ADMA logo
ADMA
(NASDAQ)
ADMA Biologics, Inc.
$8.57-- (--)
Loading... - Market loading

ADMA Biologics (ADMA) Stock Price & Financial Analysis

ADMA Biologics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.29 - $8.62
52-Week High$20.46
52-Week Low$7.21
Open$8.52
Volume8.92M
Average Volume (3M)5.00M
Market Cap1.99B
Shares Outstanding239.96M
P/E Ratio (TTM)12.06
Forward P/E15.35
Price to Sales (P/S)3.91
Price to Book (P/B)5.11
EV/EBITDA9.30
Revenue (TTM)509.86M
Net Income (TTM)165.35M
Free Cash Flow (TTM)107.80M
EPS (TTM)$0.68
Profit Margin32.43%
Operating Margin40.57%
Return on Equity (ROE)42.36%
Debt to Equity0.52
50-Day MA$9.17
200-Day MA$14.32
52-Week Change-54.16%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About ADMA Biologics

What is the current stock price for ADMA?

As of the latest trading session, ADMA stock trades at $8.31. The 52-week range is $7.21–$20.46, with a day range of $8.29–$8.62.

What is the P/E ratio for ADMA?

ADMA Biologics's trailing P/E ratio is 12.1, meaning investors pay $12.1 for every $1 of annual earnings. The forward P/E is 15.3, reflecting analyst expectations for future earnings. ADMA Biologics operates in the Healthcare sector.

Does ADMA pay dividends?

ADMA Biologics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ADMA?

Based on 3 analysts, the consensus for ADMA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ADMA?

ADMA Biologics's market capitalization is $1.99B, classifying it as a small-cap company. ADMA Biologics operates in the Healthcare sector within the Biotechnology industry.